drugset / Trial / NCT00368381

Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis

NCT00368381

Phase 4 Withdrawn CAMC Health System
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if the combination of hydrocortisone plus fludrocortisone is more efficacious than hydrocortisone alone in treating adrenal insufficiency in severe sepsis.

Timeline

Start
2006-09
Primary completion
2009-07
Completion
2009-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 50 mg Intravenous